RxDoctor Payments Data

Robert Fischer, MD

MOHS-Micrographic Surgery · Tulsa, OKNPI 1023378759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,684 of the $10,682 with a category attached, or 81.3%. It is spread thinly across 34 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,188, 2.5 times the $1,266 reported in 2019.

$10,682in general payments, 2019–2025

Across 468 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Kerecis Limited$2K
  • Regeneron Healthcare Solutions, Inc.$829
  • Johnson & Johnson$699
  • Novartis$650
  • Amgen$565
  • plus $4K from 28 others

What the payments were for

  • Travel & lodging$1,71416%
  • Food & beverage$8,68481%
  • Education$2843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$372,333
Medicare patients
226
Services billed
1,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin35$245
Mupirocin17$120
Doxycycline Hyclate19$106

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →